What is the purpose of a Corporate Integrity Agreement in healthcare?

Enhance your healthcare compliance skills with the AAHAM Certified Compliance Technician (CCT) Test. This test offers flashcards and multiple-choice questions, each with hints and detailed explanations. Prepare effectively for your certification exam!

Multiple Choice

What is the purpose of a Corporate Integrity Agreement in healthcare?

Explanation:
A Corporate Integrity Agreement is a binding agreement with the HHS Office of Inspector General that places a healthcare provider under a structured set of integrity and compliance obligations after misconduct, with the goal of keeping the provider in federal health care programs while ensuring ongoing, improved compliance. Under a CIA, the provider must implement and maintain a robust compliance program, designate a compliance officer, conduct regular training, perform internal audits, and report certain activities and investigations to the government. It may require independent monitoring for a specified period and annual certifications of compliance, along with processes to identify and remediate problem areas and overpayments. This approach lets a provider continue participating in Medicare and Medicaid programs as it makes concrete changes to prevent future violations, rather than removing them from programs entirely. It’s not about criminal prosecution, which is handled by prosecutors, nor does it grant immunity to executives. It also doesn’t involve licensing laboratories, which is a separate regulatory function.

A Corporate Integrity Agreement is a binding agreement with the HHS Office of Inspector General that places a healthcare provider under a structured set of integrity and compliance obligations after misconduct, with the goal of keeping the provider in federal health care programs while ensuring ongoing, improved compliance. Under a CIA, the provider must implement and maintain a robust compliance program, designate a compliance officer, conduct regular training, perform internal audits, and report certain activities and investigations to the government. It may require independent monitoring for a specified period and annual certifications of compliance, along with processes to identify and remediate problem areas and overpayments.

This approach lets a provider continue participating in Medicare and Medicaid programs as it makes concrete changes to prevent future violations, rather than removing them from programs entirely. It’s not about criminal prosecution, which is handled by prosecutors, nor does it grant immunity to executives. It also doesn’t involve licensing laboratories, which is a separate regulatory function.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy